Federal award (DELIVERY ORDER, fiscal year 2024)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2025-05-02 to 2025-05-05
Current total value of award: $11357.4
Description: 4568119128!NUCALA 100 MG/ML SYRINGEML